Note that the DB analyst said “branded generic” where he should have said “authorized generic.” This seems to be a common mistake, but I don’t understand why.
It is a little surprising that MNTA didn't get any higher than $26 on the intial approval. Given the level of insider, institutional and level of shorts in the stock. Of course I was also a little surprised to see that apple couldn't get past $260 on great earnings.
Not that MTNA can't work it's way higher over time.
But this only goes to show how quick this market is to cash in on any winners.
Market Data 
Markets 
AI
